Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing.

Trial Profile

Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2013

At a glance

  • Drugs Calcineurin inhibitors; Corticosteroids; Mycophenolate sodium
  • Indications Liver transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Dec 2013 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 20 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Nov 2008 Planned end date changed from 1 Oct 2008 to 1 Feb 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top